GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $83.84 $93.35 Friday, 19th Apr 2024 BMRN stock ended at $88.63. This is 1.60% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 2.14% from a day low at $88.29 to a day high of $90.18.
90 days $83.44 $94.51
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2024-04-19 $89.67 $90.18 $88.29 $88.63 1 743 531
2024-04-18 $90.25 $91.20 $89.78 $90.07 925 981
2024-04-17 $91.14 $91.53 $90.02 $90.47 1 226 760
2024-04-16 $90.93 $91.78 $90.16 $90.87 1 207 251
2024-04-15 $92.58 $93.35 $90.97 $91.51 1 906 869
2024-04-12 $91.26 $93.26 $91.09 $92.22 2 343 767
2024-04-11 $90.99 $91.59 $89.35 $91.46 2 045 255
2024-04-10 $88.38 $90.41 $87.79 $90.21 2 179 966
2024-04-09 $87.35 $89.19 $87.35 $88.98 1 151 522
2024-04-08 $87.00 $88.11 $86.96 $87.28 1 063 248
2024-04-05 $86.46 $87.21 $86.02 $86.95 798 088
2024-04-04 $86.78 $88.13 $86.63 $86.89 1 138 947
2024-04-03 $86.48 $87.72 $86.48 $86.78 1 103 456
2024-04-02 $86.25 $86.94 $85.62 $86.80 863 643
2024-04-01 $86.98 $87.31 $86.09 $87.10 616 432
2024-03-28 $88.34 $88.66 $86.65 $87.34 928 414
2024-03-27 $88.18 $88.74 $87.94 $88.61 960 055
2024-03-26 $86.94 $87.86 $86.52 $87.74 1 319 341
2024-03-25 $84.70 $86.99 $84.70 $86.52 1 385 930
2024-03-22 $84.35 $85.29 $83.90 $85.13 859 209
2024-03-21 $84.99 $85.25 $83.84 $84.11 886 926
2024-03-20 $85.01 $85.18 $83.85 $84.76 829 986
2024-03-19 $84.43 $85.60 $83.77 $85.27 1 242 267
2024-03-18 $84.13 $84.67 $83.66 $83.81 1 398 835
2024-03-15 $84.56 $84.75 $83.44 $83.87 1 071 352
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT